Microsoft and Meta shares dip as results fail to meet investors' expectations on AI delivery

S&P 500 and Nasdaq both fell

Sorin Dojan
clock • 3 min read

The latest results from Microsoft and Meta have spurred mixed reactions from investors and markets, with share prices in both companies taking a dip after the tech giants posted their quarterly figures.

According to data from MarketWatch, Microsoft's shares were down 3.8% in pre-market trading at the time of reporting on Thursday (31 October). Meta's stock also took a blow, with its shares 2.7% lower in pre-market trading. In addition, the S&P 500 futures index, which indicates the likely direction of the US stock market, was down by 0.3% at the time of reporting, while the S&P 500, which represents the actual value of the stocks included in the index, also saw a decline of 0.3%. Meanwhile, the Nasdaq Composite was 0.5% lower than a day earlier. BlackRock and Microsoft partner ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot